A type-II positive allosteric modulator of α7 nAChRs reduces brain Injury and Improves neurological function after focal cerebral ischemia in rats
dc.contributor.author | Sun, Fen | |
dc.contributor.author | Jin, Kunlin | |
dc.contributor.author | Uteshev, Victor | |
dc.date.accessioned | 2019-09-12T14:26:34Z | |
dc.date.available | 2019-09-12T14:26:34Z | |
dc.date.issued | 2013 | |
dc.description.abstract | In the absence of clinically-efficacious therapies for ischemic stroke there is a critical need for development of new therapeutic concepts and approaches for prevention of brain injury secondary to cerebral ischemia. This study tests the hypothesis that administration of PNU-120596, a type-II positive allosteric modulator (PAM-II) of α7 nicotinic acetylcholine receptors (nAChRs), as long as 6 hours after the onset of focal cerebral ischemia significantly reduces brain injury and neurological deficits in an animal model of ischemic stroke. Focal cerebral ischemia was induced by a transient (90 min) middle cerebral artery occlusion (MCAO). Animals were then subdivided into two groups and injected intravenously (i.v.) 6 hours post-MCAO with either 1 mg/kg PNU-120596 (treated group) or vehicle only (untreated group). Measurements of cerebral infarct volumes and neurological behavioral tests were performed 24 hrs post-MCAO. PNU-120596 significantly reduced cerebral infarct volume and improved neurological function as evidenced by the results of Bederson, rolling cylinder and ladder rung walking tests. These results forecast a high therapeutic potential for PAMs-II as effective recruiters and activators of endogenous α7 nAChR-dependent cholinergic pathways to reduce brain injury and improve neurological function after cerebral ischemic stroke. | |
dc.description.sponsorship | This study was supported by the National Institutes of Health Grant DK-082625 and the Start-Up funds from UNTHSC to V.V. Uteshev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | |
dc.identifier.citation | Sun F, Jin K, Uteshev VV. A type-II positive allosteric modulator of a7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats. PLoS ONE. 2013;8(8) | |
dc.identifier.uri | https://hdl.handle.net/20.500.12503/29671 | |
dc.identifier.uri | https://doi.org/10.1371/journal.pone.0073581 | |
dc.publisher | PLoS ONE | |
dc.subject.mesh | Brain Ischemia, therapy | |
dc.subject.mesh | Stroke, therapy | |
dc.subject.mesh | Receptors, Nicotinic | |
dc.subject.mesh | Allosteric Regulation | |
dc.subject.mesh | Cholinergic Agents | |
dc.title | A type-II positive allosteric modulator of α7 nAChRs reduces brain Injury and Improves neurological function after focal cerebral ischemia in rats | |
dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- A Type-II Positive Allosteric Modulator of _7 nAChRs Reduces Brai.pdf
- Size:
- 643.83 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: